Nectar Lifesciences Limited — Others, 09-07-2025: Copy of Newspaper Publication

Nectar Lifesciences Ltd. has announced a board meeting to consider the financial results for the quarter and half-year. The company reported a decline in total income from operations to Rs. 491.10 Cr (consolidated) in the latest quarter, slightly lower than the previous period. It posted a net loss before tax of Rs. 187.67 Cr and a net loss after tax of Rs. 130.09 Cr for the quarter, compared to a profit in the previous year. Earnings per share stood negative at Rs. (5.80). This indicates operational challenges impacting profitability, which is key for investors monitoring the company’s turnaround prospects.